India's Venus Remedies rises on marketing approval for cancer drugs

Venus Remedies

23/02/2023 07:03

** Shares of pharma co Venus Remedies  VENR.NS  rise as much
18.4% to 175 rupees, their highest since Jan 13
    ** Co says it has received marketing approval for its
generic cancer drugs from Uzbekistan and Palestine
    ** Drugs expected to be launched in the two countries in
next financial year
    ** Stock trading above 50-day simple moving avg as of 12:14
a.m. IST
    ** More than 138,211 shares change hands by 12:14 a.m. IST,
4.7x 30-day avg of 29,724 shares
    ** Shares change hands most since Sept. 19, 2022
    ** Stock down 18.4% YTD up to last close; fell 55.7% in 2022
 (Reporting by Anuran Sadhu in Bengaluru)
 ((Anuran.Sadhu@thomsonreuters.com ;))